The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Table 3

Comparison of PASI, VAS, and DLQI scores in the treatment group at the baseline, weeks 4, 8, and 12.

Variable/time	Baseline	week 4	week 8	week 12
PASI	7.22 ± 0.61a	6.7 ± 0.60b	5.67 ± 0.49c	4.08 ± 0.39d
VAS	57.64 ± 4.64a	50.44 ± 4.51b	41.8 ± 4.43c	32.24 ± 4.29d
DLQI	11.88 ± 0.90a	10.76 ± 0.83b	8.96 ± 0.73c	6.56 ± 0.63d

The difference letters in each row show significant difference at .